PharmaShots | Incisive News in 3 Shots

Subscribe Now

Astria Therapeutics

Astria Therapeutics’ Navenibart Gains the US FDA’s Orphan Drug Designation to Treat Hereditary Angioedema

Astria Therapeutics’ Navenibart Gains the US FDA’s Orphan Drug Designation to Treat Hereditary Angioedema

September 30, 2024

Astria Therapeutics Signs an Exclusive License Agreement with Ichnos Sciences for OX40 Portfolio in Atopic Dermatitis and other Allergic and Immunological Diseases

Astria Therapeutics Signs an Exclusive License Agreement with Ichnos Sciences for OX40 Portfolio in Atopic Dermatitis and other Al...

October 12, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us